Behavioral Economics for Advance Care Options
BEACON
1 other identifier
interventional
80
1 country
1
Brief Summary
People with life-limiting illness often receive more aggressive healthcare than desired including costly procedures that provide little medical benefit. Advance Directives (AD) can reduce this effect but various factors limit their adoption. A randomized trial will target hospitalized patients with a serious, life limiting illness to test if the behavioral economics principles of endowment (possessing something) and focusing (featuring something important to patients) can motivate AD completion. Investigators will examine if offering patients an AD by default, in combination with framing the rationale for AD completion (emphasizing patient control or caregiver burden) improves AD completion and family conversation compared to a no-intervention group. The study hypothesis is to determine if rates of AD completion and family conversations will be highest among patients receiving the intervention focused on reduced caregiver burden; and if the two intervention groups will have higher rates of both than the control group. The investigators suspect that a small change in how patient information is framed (endowment and focusing used in tandem) will potentially leverage large increases in AD completion and that targeting HHC patients allows AD discussions early in the disease trajectory when they can participate in care decisions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2014
CompletedFirst Posted
Study publicly available on registry
April 1, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJuly 27, 2021
July 1, 2021
3.5 years
March 27, 2014
July 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Advance directive document completion
The number of advance directive documents completed within one month of enrollment.
1 month
Secondary Outcomes (1)
Advance Directive document completion
1 year
Other Outcomes (1)
Advance directive communication
1 year
Study Arms (2)
Behavioral Counseling
EXPERIMENTALProvide an advance directive document to patients along with counseling that either focuses on care giver burden or on patient autonomy.
Standard AD
NO INTERVENTIONThe topic of advance directives (AD) is introduced but patient receives an AD document only upon request.
Interventions
An advance directive (AD) document is provided to the patient along with counseling that focuses on care giver burden as the reason for adoption of the AD.
An advance directive (AD) document is provided to the patient along with counseling that focuses on patient autonomy (control) as the reason for adoption of the AD.
Eligibility Criteria
You may qualify if:
- years or older
- One or more of the following:
- Chronic obstructive pulmonary disease
- End stge renal disease
- Peripheral vascular disease
- NYHA class II or V heart failure
- Cancer
- Neuromuscular / movement disorder
You may not qualify if:
- Patient referred to palliative care
- Patient has advance directive
- Patient has impaired decision making ability
- Patient previously enrolled in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ascension Healthlead
- University of Pennsylvaniacollaborator
- Robert Wood Johnson Foundationcollaborator
Study Sites (1)
Genesys Regional Medical Center
Grand Blanc, Michigan, 48439, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark E Vogel, PhD
Ascension Health
- PRINCIPAL INVESTIGATOR
Scott Halpern, MD, PhD
University of Pennsylvania
- STUDY DIRECTOR
Kimberly R Barber, PhD
Genesys Regional Medical Director
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Behavioral Science and Psychology
Study Record Dates
First Submitted
March 27, 2014
First Posted
April 1, 2014
Study Start
April 1, 2014
Primary Completion
October 1, 2017
Study Completion
October 1, 2019
Last Updated
July 27, 2021
Record last verified: 2021-07